Table 3.
Scenario | # gene | coef. | Approach | Pos. 1 | Pos. 2 | TP 1 | TP 2 | Overlap |
---|---|---|---|---|---|---|---|---|
1 | 20 | 0.25 | Mc.TGD | 13 | 12 | 10 | 10 | 5 |
TGDR | 15 | 16 | 10 | 10 | 5 | |||
2 | 20 | 0.35 | Mc.TGD | 12 | 12 | 10 | 10 | 5 |
TGDR | 14 | 14 | 10 | 10 | 5 | |||
3 | 500 | 0.25 | Mc.TGD | 28 | 27 | 9 | 10 | 5 |
TGDR | 35 | 35 | 10 | 9 | 4 | |||
4 | 500 | 0.35 | Mc.TGD | 24 | 25 | 10 | 9 | 5 |
TGDR | 34 | 34 | 10 | 9 | 5 | |||
5 | 1000 | 0.25 | Mc.TGD | 31 | 31 | 9 | 9 | 5 |
TGDR | 39 | 38 | 9 | 9 | 4 | |||
6 | 1000 | 0.35 | Mc.TGD | 30 | 30 | 10 | 9 | 5 |
TGDR | 37 | 38 | 10 | 9 | 5 |
Pos. 1 (2): number of genes identified to be associated with cancer 1 (2); TP 1 (2): number of true positives for cancer 1 (2); Overlap: number of genes identified to be associated with both cancers.